| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology (Drs. Federoff and Kurlan) and Center for Aging and Developmental Biology (Drs. Coleman, Federoff, and Kurlan), University of Rochester School of Medicine, NY.
Address correspondence and reprint requests to Dr. R. Kurlan, University of Rochester School of Medicine, 601 Elmwood Ave., Rochester, NY 14642-8673; e-mail: Roger_Kurlan{at}urmc.rochester.edu
Synaptic dysfunction and failure are processes that occur early in Alzheimer disease (AD) and are important targets for protective treatments to slow AD progression and preserve cognitive and functional abilities. Synaptic loss is the best current pathologic correlate of cognitive decline, and synaptic dysfunction is evident long before synapses and neurons are lost. Once synaptic function fails, even in the setting of surviving neurons, there may be little chance of effectively interfering with the disease process. This review emphasizes the importance of preserving synaptic structure and function (i.e., "synaptoprotection") in AD. Such "synaptoprotective" therapy will probably need to be administered at a critical early time point, perhaps years before onset of clinical symptoms.
Received August 14, 2003. Accepted in final form April 12, 2004.
This article has been cited by other articles:
|
|
 |
|
  R. M. LoPachin, D. S. Barber, and T. Gavin Molecular Mechanisms of the Conjugated {alpha},{beta}-Unsaturated Carbonyl Derivatives: Relevance to Neurotoxicity and Neurodegenerative Diseases Toxicol. Sci., August 1, 2008; 104(2): 235 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang, B. Su, H. Fujioka, and X. Zhu Dynamin-Like Protein 1 Reduction Underlies Mitochondrial Morphology and Distribution Abnormalities in Fibroblasts from Sporadic Alzheimer's Disease Patients Am. J. Pathol., August 1, 2008; 173(2): 470 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Dickerson, A. Bakkour, D. H. Salat, E. Feczko, J. Pacheco, D. N. Greve, F. Grodstein, C. I. Wright, D. Blacker, H. D. Rosas, et al. The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals Cereb Cortex, July 16, 2008; (2008) bhn113v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S L Miller, E Fenstermacher, J Bates, D Blacker, R A Sperling, and B C Dickerson Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline J. Neurol. Neurosurg. Psychiatry, June 1, 2008; 79(6): 630 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Revuelta, A. Rosso, and C. F. Lippa Neuritic Pathology as a Correlate of Synaptic Loss in Dementia With Lewy Bodies American Journal of Alzheimer's Disease and Other Dementias, March 1, 2008; 23(1): 97 - 102. [Abstract] [PDF]
|
|
|
|
|
|
S. Albrecht, M. Bourdeau, D. Bennett, E. J. Mufson, M. Bhattacharjee, and A. C. LeBlanc Activation of Caspase-6 in Aging and Mild Cognitive Impairment Am. J. Pathol., April 1, 2007; 170(4): 1200 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. N. Lacor, M. C. Buniel, P. W. Furlow, A. Sanz Clemente, P. T. Velasco, M. Wood, K. L. Viola, and W. L. Klein A{beta} Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease J. Neurosci., January 24, 2007; 27(4): 796 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S Parihar and G. J. Brewer Mitoenergetic failure in Alzheimer disease Am J Physiol Cell Physiol, January 1, 2007; 292(1): C8 - C23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Schindowski, A. Bretteville, K. Leroy, S. Begard, J.-P. Brion, M. Hamdane, and L. Buee Alzheimer's Disease-Like Tau Neuropathology Leads to Memory Deficits and Loss of Functional Synapses in a Novel Mutated Tau Transgenic Mouse without Any Motor Deficits Am. J. Pathol., August 1, 2006; 169(2): 599 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Petrella, S. Krishnan, M. J. Slavin, T.-T. T. Tran, L. Murty, and P. M. Doraiswamy Mild Cognitive Impairment: Evaluation with 4-T Functional MR Imaging Radiology, July 1, 2006; 240(1): 177 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Gillingwater, C. A. Ingham, K. E. Parry, A. K. Wright, J. E. Haley, T. M. Wishart, G. W. Arbuthnott, and R. R. Ribchester Delayed synaptic degeneration in the CNS of Wlds mice after cortical lesion Brain, June 1, 2006; 129(6): 1546 - 1556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Roselli, M. Tirard, J. Lu, P. Hutzler, P. Lamberti, P. Livrea, M. Morabito, and O. F. X. Almeida Soluble {beta}-Amyloid1-40 Induces NMDA-Dependent Degradation of Postsynaptic Density-95 at Glutamatergic Synapses J. Neurosci., November 30, 2005; 25(48): 11061 - 11070. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Desai and G. T. Grossberg Diagnosis and treatment of Alzheimer's disease Neurology, June 28, 2005; 64(12_suppl_3): S34 - S39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Brenner, R. Kurlan, P. Coleman, and H. Federoff A focus on the synapse for neuroprotection in Alzheimer disease and other dementias Neurology, June 14, 2005; 64(11): 1991 - 1991. [Full Text] [PDF]
|
|
Read all Correspondence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
